18F-LBT-999
C22-62
Phase 3 small_molecule active
Quick answer
18F-LBT-999 for Comatose Traumatic Brain Injury patients is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Comatose Traumatic Brain Injury patients
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active